{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:24:49Z","timestamp":1787019889058,"version":"build-2736575974"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T00:00:00Z","timestamp":1267488000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T00:00:00Z","timestamp":1267488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The purpose of this study was to examine the diagnostic performance of autoantibodies against citrullinated peptides\/proteins (ACPA) and to determine the prevalence of HLA-DRB1 shared epitope alleles (SE) in African patients with rheumatoid arthritis (RA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum levels of anti-cyclic citrullinated peptides antibodies (anti-CCP2, anti-CCP3), IgM and IgA rheumatoid factors (RF) were measured by enzyme-linked immunosorbent assay in the serum of 56 consecutive RA patients regularly followed in the Rheumatology Unit of the School of Medicine, University of Yaound\u00e9, Yaound\u00e9, Cameroon. Genotyping of HLA-DRB1 alleles was performed by polymerase chain reaction and hybridization with sequence-specific oligonucleotide probes on microbeads arrays. Fifty-one patients with other inflammatory rheumatic diseases and 50 healthy individuals were included as controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>An anti-CCP2 assay showed the best diagnosis sensitivity (82%) and specificity (98%) with high positive predictive (PPV) (96%) and negative predictive values (NPV) (91%). Thirty percent of RA patients were carrying at least one copy of the HLA-DRB1 shared epitope (SE) compared to 10% and 14% of patients with other inflammatory rheumatic diseases and healthy individuals, respectively. The presence of the SE was associated with the production of ACPA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-CCP2 antibodies are useful markers of RA in African patients. In this cohort, the prevalence of the SE is higher in RA patients than in controls but lower than that reported in patient cohorts of European ancestry. The discrepancy between the high prevalence of ACPA-positive patients and the relatively low number of SE-positive cases suggest that, in addition to SE, other genetic factors control the development of ACPA in African RA patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/ar2945","type":"journal-article","created":{"date-parts":[[2010,3,25]],"date-time":"2010-03-25T15:15:18Z","timestamp":1269530118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients"],"prefix":"10.1186","volume":"12","author":[{"given":"Madeleine","family":"Singwe-Ngandeu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Finckh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvette","family":"Bas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Tiercy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Gabay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,2]]},"reference":[{"key":"2780_CR1","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/ard.34.2.136","volume":"34","author":"P Beighton","year":"1975","unstructured":"Beighton P, Solomon L, Valkenburg HA: Rheumatoid arthritis in a rural South African Negro population. Ann Rheum Dis. 1975, 34: 136-141. 10.1136\/ard.34.2.136.","journal-title":"Ann Rheum Dis"},{"key":"2780_CR2","first-page":"405","volume":"15","author":"SW Brighton","year":"1988","unstructured":"Brighton SW, de la Harpe AL, van Staden DJ, Badenhorst JH, Myers OL: The prevalence of rheumatoid arthritis in a rural African population. J Rheumatol. 1988, 15: 405-408.","journal-title":"J Rheumatol"},{"key":"2780_CR3","first-page":"618","volume":"20","author":"AJ Silman","year":"1993","unstructured":"Silman AJ, Ollier W, Holligan S, Birrell F, Adebajo A, Asuzu MC, Thomson W, Pepper L: Absence of rheumatoid arthritis in a rural Nigerian population. J Rheumatol. 1993, 20: 618-622.","journal-title":"J Rheumatol"},{"key":"2780_CR4","doi-asserted-by":"crossref","first-page":"585","DOI":"10.4049\/jimmunol.162.1.585","volume":"162","author":"E Girbal-Neuhauser","year":"1999","unstructured":"Girbal-Neuhauser E, Durieux JJ, Arnaud M, Dalbon P, Sebbag M, Vincent C, Simon M, Senshu T, Masson-Bessiere C, Jolivet-Reynaud C, Jolivet M, Serre G: The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues. J Immunol. 1999, 162: 585-594.","journal-title":"J Immunol"},{"key":"2780_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1172\/JCI1316","volume":"101","author":"GA Schellekens","year":"1998","unstructured":"Schellekens GA, de Jong BA, Hoogen van den FH, Putte van de LB, van Venrooij WJ: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest. 1998, 101: 273-281. 10.1172\/JCI1316.","journal-title":"J Clin Invest"},{"key":"2780_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/ard.2007.071654","volume":"67","author":"B Vander Cruyssen","year":"2008","unstructured":"Cruyssen Vander B, Nogueira L, Van Praet J, Deforce D, Elewaut D, Serre G, De Keyser F: Do all anti-citrullinated protein\/peptide antibody tests measure the same? Evaluation of discrepancy between anti-citrullinated protein\/peptide antibody tests in patients with and without rheumatoid arthritis. Ann Rheum Dis. 2008, 67: 542-546. 10.1136\/ard.2007.071654.","journal-title":"Ann Rheum Dis"},{"key":"2780_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B","volume":"43","author":"AJ MacGregor","year":"2000","unstructured":"MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, Silman AJ: Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000, 43: 30-37. 10.1002\/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B.","journal-title":"Arthritis Rheum"},{"key":"2780_CR8","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1399-0004.1989.tb03185.x","volume":"36","author":"CM Deighton","year":"1989","unstructured":"Deighton CM, Walker DJ, Griffiths ID, Roberts DF: The contribution of HLA to rheumatoid arthritis. Clin Genet. 1989, 36: 178-182.","journal-title":"Clin Genet"},{"key":"2780_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/S0140-6736(09)60008-8","volume":"373","author":"L Klareskog","year":"2009","unstructured":"Klareskog L, Catrina AI, Paget S: Rheumatoid arthritis. Lancet. 2009, 373: 659-672. 10.1016\/S0140-6736(09)60008-8.","journal-title":"Lancet"},{"key":"2780_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002\/art.1780310302.","journal-title":"Arthritis Rheum"},{"key":"2780_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, Putte van de LB, van Riel PL: Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995, 38: 44-48. 10.1002\/art.1780380107.","journal-title":"Arthritis Rheum"},{"key":"2780_CR12","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1136\/ard.61.6.505","volume":"61","author":"S Bas","year":"2002","unstructured":"Bas S, Perneger TV, Kunzle E, Vischer TL: Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis. 2002, 61: 505-510. 10.1136\/ard.61.6.505.","journal-title":"Ann Rheum Dis"},{"key":"2780_CR13","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/rheumatology\/41.7.809","volume":"41","author":"S Bas","year":"2002","unstructured":"Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA: Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford). 2002, 41: 809-814. 10.1093\/rheumatology\/41.7.809.","journal-title":"Rheumatology (Oxford)"},{"key":"2780_CR14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1093\/rheumatology\/keg184","volume":"42","author":"S Bas","year":"2003","unstructured":"Bas S, Genevay S, Meyer O, Gabay C: Anti-cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford). 2003, 42: 677-680. 10.1093\/rheumatology\/keg184.","journal-title":"Rheumatology (Oxford)"},{"key":"2780_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2007.08.002","volume":"386","author":"L Lutteri","year":"2007","unstructured":"Lutteri L, Malaise M, Chapelle JP: Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis. Clin Chim Acta. 2007, 386: 76-81. 10.1016\/j.cca.2007.08.002.","journal-title":"Clin Chim Acta"},{"key":"2780_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s10067-008-0999-5","volume":"28","author":"LM dos Anjos","year":"2009","unstructured":"dos Anjos LM, Pereira IA, d 'Orsi E, Seaman AP, Burlingame RW, Morato EF: A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis. Clin Rheumatol. 2009, 28: 153-158. 10.1007\/s10067-008-0999-5.","journal-title":"Clin Rheumatol"},{"key":"2780_CR17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1399-0039.2007.00993.x","volume":"71","author":"M Rahal","year":"2008","unstructured":"Rahal M, Kervaire B, Villard J, Tiercy JM: DNA typing by microbead arrays and PCR-SSP: apparent false-negative or -positive hybridization or amplification signals disclose new HLA-B and -DRB1 alleles. Tissue Antigens. 2008, 71: 238-241. 10.1111\/j.1399-0039.2007.00993.x.","journal-title":"Tissue Antigens"},{"key":"2780_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1034\/j.1399-0039.2001.580101.x","volume":"58","author":"N Pimtanothai","year":"2001","unstructured":"Pimtanothai N, Hurley CK, Leke R, Klitz W, Johnson AH: HLA-DR and -DQ polymorphism in Cameroon. Tissue Antigens. 2001, 58: 1-8. 10.1034\/j.1399-0039.2001.580101.x.","journal-title":"Tissue Antigens"},{"key":"2780_CR19","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1002\/art.24716","volume":"60","author":"MP van der Linden","year":"2009","unstructured":"Linden van der MP, Woude van der D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, Helm-van Mil van der AH: Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis. Arthritis Rheum. 2009, 60: 2232-2241. 10.1002\/art.24716.","journal-title":"Arthritis Rheum"},{"key":"2780_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1399-0039.1990.tb01813.x","volume":"36","author":"RW Martell","year":"1990","unstructured":"Martell RW, Stein M, Davis P, West G, Emmanuel J, du Toit ED: The association between HLA and rheumatoid arthritis in Zimbabwean blacks. Tissue Antigens. 1990, 36: 125-126. 10.1111\/j.1399-0039.1990.tb01813.x.","journal-title":"Tissue Antigens"},{"key":"2780_CR21","first-page":"111","volume":"42","author":"A Dieye","year":"1997","unstructured":"Dieye A, Diallo S, Diatta M, Thiam A, Ndiaye R, Bao O, Sarthou JL: [Identification of HLA-DR alleles for susceptibility to rheumatoid polyarthritis in Senegal]. Dakar Med. 1997, 42: 111-113.","journal-title":"Dakar Med"},{"issue":"Suppl 3","key":"2780_CR22","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.1186\/ar578","volume":"4","author":"AJ Silman","year":"2002","unstructured":"Silman AJ, Pearson JE: Epidemiology and genetics of rheumatoid arthritis. Arthritis Res. 2002, 4 (Suppl 3): S265-272. 10.1186\/ar578.","journal-title":"Arthritis Res"},{"key":"2780_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X","volume":"42","author":"W Thomson","year":"1999","unstructured":"Thomson W, Harrison B, Ollier B, Wiles N, Payton T, Barrett J, Symmons D, Silman A: Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: results from a large, population-based study. Arthritis Rheum. 1999, 42: 757-762. 10.1002\/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X.","journal-title":"Arthritis Rheum"},{"key":"2780_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/art.23166","volume":"58","author":"LB Hughes","year":"2008","unstructured":"Hughes LB, Morrison D, Kelley JM, Padilla MA, Vaughan LK, Westfall AO, Dwivedi H, Mikuls TR, Holers VM, Parrish LA, Alarc\u00f3n GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Gilkeson GS, Howard G, Moreland LW, Patterson N, Reich D, Bridges SL: The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Arthritis Rheum. 2008, 58: 349-358. 10.1002\/art.23166.","journal-title":"Arthritis Rheum"},{"key":"2780_CR25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/art.11000","volume":"49","author":"I Del Rincon","year":"2003","unstructured":"Del Rincon I, Battafarano DF, Arroyo RA, Murphy FT, Fischbach M, Escalante A: Ethnic variation in the clinical manifestations of rheumatoid arthritis: role of HLA-DRB1 alleles. Arthritis Rheum. 2003, 49: 200-208. 10.1002\/art.11000.","journal-title":"Arthritis Rheum"},{"key":"2780_CR26","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/art.21575","volume":"54","author":"L Klareskog","year":"2006","unstructured":"Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J, Ronnelid J, Harris HE, Ulfgren AK, Rantapaa-Dahlqvist S, Eklund A, Padyukov L, Alfredsson L: A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006, 54: 38-46. 10.1002\/art.21575.","journal-title":"Arthritis Rheum"},{"key":"2780_CR27","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.21739","volume":"54","author":"AH van der Helm-van Mil","year":"2006","unstructured":"Helm-van Mil van der AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR: The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum. 2006, 54: 1117-1121. 10.1002\/art.21739.","journal-title":"Arthritis Rheum"},{"key":"2780_CR28","doi-asserted-by":"publisher","first-page":"e1000424","DOI":"10.1371\/journal.pgen.1000424","volume":"5","author":"JM Kelley","year":"2009","unstructured":"Kelley JM, Hughes LB, Faggard JD, Danila MI, Crawford MH, Edberg Y, Padilla MA, Tiwari HK, Westfall AO, Alarcon GS, Conn DL, Jonas BL, Callahan LF, Smith EA, Brasington RD, Allison DB, Kimberly RP, Moreland LW, Edberg JC, Bridges SL: An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans. PLoS Genet. 2009, 5: e1000424-10.1371\/journal.pgen.1000424.","journal-title":"PLoS Genet"},{"key":"2780_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/art.22373","volume":"56","author":"AH van der Helm-van Mil","year":"2007","unstructured":"Helm-van Mil van der AH, Verpoort KN, le Cessie S, Huizinga TW, de Vries RR, Toes RE: The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. Arthritis Rheum. 2007, 56: 425-432. 10.1002\/art.22373.","journal-title":"Arthritis Rheum"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2945\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2945.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T06:55:01Z","timestamp":1728370501000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,2]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2010,4]]}},"alternative-id":["2780"],"URL":"https:\/\/doi.org\/10.1186\/ar2945","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,2]]},"assertion":[{"value":"16 October 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R36"}}